Latest "New England Anti-Vivisection Society" News Stories

18:45 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "New England Anti-Vivisection Society" found in our extensive news archives from over 250 global news sources.

More Information about New England Anti-Vivisection Society on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about New England Anti-Vivisection Society for you to read. Along with our medical data and news we also list New England Anti-Vivisection Society Clinical Trials, which are updated daily. BioPortfolio also has a large database of New England Anti-Vivisection Society Companies for you to search.

Showing "England Anti Vivisection Society" News Articles 1–25 of 7,600+

Wednesday 19th September 2018

joimax® Introduces Intracs® em Electromagnetic Navigation System

New Minimally Invasive Device Exhibited at EUROSPINE Barcelona and NASS Los Angeles joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic spinal surgery, introduces another minimally invasive device, Intracs® em Electromagnetic Navigation System, at two global spine events: EUROSPINE Barcelona, the Spine ...

Cerner Selected for NHS Framework to Support Integrated Care and Population Health

Integrated Care Systems (ICS) and Sustainability and Transformation Partnerships (STPs) aim to deliver the best possible quality of health and care, shift to value-based care and proactively improve outcomes for their populations. These transformation initiatives can now be more easily supported by sourcing a range of innovative services and technologies through NHS England’s new Health Systems ...

CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board

Regulatory News: Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced that Stephan A. Grupp, MD, Ph.D., a leading pediatric oncologist at

Obesity and Vitamin D Deficiency May Indicate Greater Risk for Breast Cancer

NewsNew study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis.

Facet Team Member Contributes to Recent Pediatric Dermatology Publication

Head of R&D Co-authors Journal Article WAYNE, Pa. (PRWEB) September 19, 2018 Facet Life Sciences, a leading provider of development software and services for small and growing life sciences teams, today announced the publication of “Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation” in Pediatric Dermatology, the official journal of the Socie...

Anti-inflammatory Protein Promotes Healthy Gut

NewsScientists have discovered that an anti-inflammatory protein helped protect mice against obesity and insulin resistance when they were fed a high-fat diet.

Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26

Superior Controls will attend the 27th Annual International Society of Pharmaceutical Engineering (ISPE) Boston Area Chapter Product Show and Career Fair at Gillette Stadium in Foxborough, MA September 26, 2018 from 10:00 am - 5:30 pm SEABROOK, N.H. (PRWEB) September 19, 2018 Superior Controls, Inc., a leading control system integrator of custom industrial automation and IT solutions with 150 emp...

Revitalize Laser Care Brings Leading-Edge Technology and Extensive Medical Expertise to Tattoo Removal in Denver

Medical Doctor performs all tattoo removal treatments at state-of-the-art Revitalize Laser Care clinic “Live with no regrets, but reserve the right to change your mind.” This is how millions of Americans feel about their tattoos. Over the past decade, demand for tattoo removal has grown rapidly. Top reasons consumers report wanting to remove tattoo...

New pay deal for NHS staff in Wales 'goes beyond' deal for England

NHS staff in Wales are set to benefit from a new pay deal over the next three years which is set to match, if not go beyond, the pay deal for England, according to the Welsh government.

IMBiotechnologies Ltd Announces Presentation at the 2018 Cardiovascular and Interventional Radiological Society of Europe Annual Meeting (Lisbon, Portugal)

IMBiotechnologies Ltd. today announced that an oral presentation regarding the use of its lead product, Occlusin® 500 Embolization Microspheres (Occlusin 500), in benign prostatic hypertrophy (BPH) patients will be presented at the 2018 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting. Dr. Richard Owen, lead investig...

Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of Yupelri in COPD

DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Sept. 17, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ :TBPH ) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ :MYL ) (“Mylan”) today announced that positive new data from the companies’ Phase 3 clinical program for YUPELRI™ (revefenacin) inhalation solution were featured in an oral presentation at th...

Dozens of Medical Groups Join Forces to Improve Diagnoses

WEDNESDAY, Sept. 19, 2018 -- Every nine minutes, a patient in a U.S. hospital dies because a diagnosis was wrong or delayed -- resulting in 80,000 deaths a year. That sobering estimate comes from the Society to Improve Diagnosis in Medicine...

Novaliq to Present at the Ophthalmology Futures Forums on How to Break the Vicious Circle of Dry Eye Disease

Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, will present at the upcoming Ophthalmology Futures Forums in Vienna. The Ophthalmology Futures F

Clinical Trial Data for Nintedanib in Patients with Advanced Idiopathic Pulmonary Fibrosis Published

Ingelheim, Germany, 16 September 2018 – Results from the INSTAGE® trial have been presented at the 2018 European Respiratory Society (ERS) conference in Paris and published in the New England Journal of Medicine.1 The trial reports clinical data on a subset of patients with IPF and severe impairment in gas exchange, for whom only limited data exist. Data suggest …

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.

PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Victims

Anbu Kochi joins hands with PULSUS Group in support of Kerala Flood Victims SINGAPORE and LONDON, Sept. 19, 2018 /PRNewswire/ -- In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid rel...

Targeted Oncology™ Launches its Latest Virtual Tumor Board on Multiple Myeloma

Distinguished experts to provide in-depth insights on four patients with multiple myeloma Targeted Oncology™, a print and digital resource that offers content and expert opinions on standard and emerging treatments in the oncology field, will launch its third “Expert Perspective: Virtual Tumor Board” on Monday, September 24. Each Virtual Tumor Bo...

Reliance on News Media Surges Among Americans Seeking Facts About Corporate Social and Environmental Responsibility

Nearly two-thirds are unsure about the promises of elected officials beyond thoughts and prayers during public crises The 2018 G&S Business Communications Sense & Sustainability® Study is the firm’s ninth annual U.S. public opinion poll about business and government commitment to protecting society and the environment. ...

New Book 'Project You' Introduces Powerful Anti-Aging, Anti-Cancer Superfoods to U.S. Market

SAN FRANCISCO, Sept. 19, 2018 /PRNewswire/ -- Author and women's health advocate Neely Mack has released her new book, Project You: A Lifestyle Guide to Read more...

3D Pathology: A New Molecular Imaging Technique Wins World Molecular Imaging Congress VC Session

A Shark Tank session was held on Thursday evening September 13, 2018 at the WMIC in Seattle. CULVER CITY, Calif. (PRWEB) September 19, 2018 Five venture capitalists and angel investors evaluated five different companies. Vivek Paul, Thomas J. Meade, PhD, Ajit Singh, PhD, David M. Hadley, PhD, and Brian Chow, PhD, unanimously chose Lightspeed Microscopy as a fundable start-up company with great po...

Catabasis Pharmaceuticals to Present New Edasalonexent Clinical Results and Phase 3 Trial Design in Duchenne Muscular Dystrophy at the World Muscle Society Congress

-- Late Breaking Presentation of Data Supporting MRI T2 as a Potential Marker of Clinical Outcome in Duchenne – -- Presentations on MoveDMD Clinical Results and Polaris DMD Phase 3 Design – Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announce

The NHS heart age test will overload GPs who are already under huge pressure

“Why are so many of us heading for an early grave?” asked the Guardian last week. The NHS online heart age test made headlines when Public Health England revealed that 81% of the 1.9 million people...

Charleston, SC Sleep Apnea Suffers Receive Relief from Dr. Kevin Hogan

Dr. Kevin Hogan, founder of Smiles by Hogan, is encouraging those who have been diagnosed with sleep apnea in Charleston, SC and surrounding communities, to talk with him about customized dental-related treatment solutions. Addressing this condition now can lessen its immediate and systemic effects. Charleston, SC (PRWEB) September 19, 2018 General dentist Dr. Kevin Hogan at Smiles by Hogan, welc...

Exelixis’ Partner Ipsen Announces Health Canada’s Approval of CABOMETYX® (cabozantinib) Tablets for the Treatment of Adults with Previously Treated Advanced Renal Cell Carcinoma

– Approval based on the improvement in overall survival, progression-free survival and objective response rate for CABOMETYX versus everolimus in the phase 3 pivotal METEOR trial – Exelixis, Inc. (NASDAQ:EXEL) today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX®

Secarna Pharmaceuticals successfully hosted Inaugural Industry Expert Meeting and Networking Event for the Oligonucleotide Therapeutics Society (OTS) in Munich

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Conference 19.09.2018 / 11:30 The issuer is solely responsible for the content of this announcement. Secarna Pharmaceuticals successfully hosted Inaugural Industry Expert Meeting and Networking Event for the Oligonucleotide Therapeutics Society (OTS) in Munich   Secarna provided a platform for discussion and informa...

Quick Search


News Quicklinks